[1]
J. Muñoz-Cerón, “Low dose Galcanezumab for treating trigeminal autonomic cephalalgias: clinical observation from Colombia and Mexico on behalf of ASOLAC”, Headache Med, vol. 16, no. 1, pp. 65–70, Mar. 2025.